Ingredient deep-dive

Niacin And Memory: Deficiency Is Not Enhancement

Niacin is the one ingredient on this label with a genuine published link to thinking. That link runs through shortage, not through improvement, and the distance between those two ideas is where most of the marketing in this category lives.

By MemoHoney Team · Last updated November 4, 2026 · 9 min read · Ingredient deep-dive · Physician review by Dr. Schehrezade Khan, MD

What niacin actually does in a cell

Vitamin B3 is converted into nicotinamide adenine dinucleotide, NAD, and its phosphorylated form NADP. Those two molecules are electron carriers, and they turn up in glycolysis, in the Krebs cycle, in fatty acid synthesis, and in a long list of repair enzymes that depend on NAD as a substrate rather than a cofactor.

Without enough NAD a cell cannot turn food into usable energy at all. Read that way the word printed across a supplement band is chemically exact and commercially useless: it names electron transfer, not a lift. Niacin is not a stimulant.

The brain is a heavy consumer of energy for its weight, so a cofactor in energy metabolism has an obvious route to mattering there. The question, as always, is whether adding more to a system that already has enough does anything.

The deficiency link, which is real

Severe niacin deficiency produces pellagra, and the classical medical description of pellagra lists four Ds: dermatitis, diarrhoea, dementia and death. The dementia in that list is not a metaphor. It is a genuine cognitive syndrome that reverses on treatment.

It is also not confined to history. Case reports still appear in the literature, generally in the context of malnutrition, alcohol use disorder, malabsorption or restrictive eating.

So the connection between niacin and cognition is established at one end of the dose range: take enough away and thinking fails. What that does not establish is anything about the other direction. Scurvy proves vitamin C is essential; it does not make vitamin C a treatment for anything in a person who already eats fruit.

The cohort study everyone cites

There is one study that turns up behind almost every niacin-and-memory claim, and it is worth reading properly rather than repeating.

A prospective study in a geographically defined Chicago community followed 6,158 residents aged 65 and over between 1993 and 2002. Nutrient intake was determined by food frequency questionnaire. Cognitive tests were given at three-year intervals across a six-year follow-up, and 3,718 participants had both dietary data and at least two assessments.

Energy-adjusted niacin intake was associated with a lower rate of incident Alzheimer's disease and with slower cognitive decline over a median 5.5 years.

That is a genuinely interesting finding and it is an observational one. It measured what people ate, not what they supplemented. People with higher dietary niacin eat more meat, fish, poultry and fortified grain, which travels with a broader diet and with a set of social and economic factors that are hard to separate from the nutrient. Cohort studies establish association, and this one is honest about being one.

What it does not do is establish that adding a niacin capsule to an adequate diet reproduces the result. This website cites it as a dietary cohort and describes it as such every time it appears.

What happens at gram doses

The other half of the niacin literature is about amounts forty to sixty times a nutritional intake, and it is uniformly negative. It is worth knowing precisely because it is the part most likely to be quoted out of context in either direction.

Five contexts across four orders of magnitude. Conflating any two of them produces a false statement about niacin.

AIM-HIGH gave extended-release niacin at 1.5 to 2 g a day to patients with low HDL cholesterol who were already on intensive statin therapy, and found no reduction in cardiovascular events. HPS2-THRIVE gave 2 g of extended-release niacin with laropiprant to more than 25,000 high-risk patients and found no reduction in vascular events alongside an excess of serious adverse events. The AIM-HIGH safety report set out the adverse-event profile in detail.

Those trials ended niacin's career as a lipid drug. They say nothing about a capsule carrying a nutritional amount, and citing them as a safety warning about a supplement would be the same error in reverse as citing the Chicago cohort as proof a capsule works. Dose is the whole subject.

Three forms, and why a label should say which

A label that says only Niacin (Vitamin B3), as this one does, has not told you which of these is in the capsule.

The practical difference between these is the flush. Nicotinic acid produces a warm, prickling redness across the face, neck and upper chest within fifteen to thirty minutes, through a prostaglandin D2 mechanism reviewed in detail here. It is harmless, it fades within the hour, and it becomes less pronounced with continued daily use over one to two weeks.

Niacinamide does not do it at all. So a label that prints only Niacin (Vitamin B3), as this one does, leaves a buyer unable to predict the most noticeable thing that might happen on their first morning.

There is a silver lining, and on a label with no panel it is worth taking. If you do flush, you have learned two facts the label did not give you: the form is nicotinic acid, and the amount is not trivial. Write down the day and how long it lasted. The side effects page covers what to do about it, which is mostly nothing.

Adding up your own intake

This is the one practical consequence of the missing panel that applies to niacin specifically, and it is worth five minutes.

• Breakfast cereal. Fortified cereals are a substantial niacin source and the box prints the amount.
• A multivitamin. Almost all of them contain niacin, and the panel states how much.
• A B-complex. These carry considerably more than a multivitamin, often many times an ordinary daily intake.
• An energy drink. Many are heavily fortified with B vitamins including niacin.
• This capsule. Unknown, because the label prints no figure.

The honest position is that you cannot total it exactly while one of the five lines is blank. What you can do is know the other four, which is the next best thing and takes one reading of four labels you already own.

If you flush on the first morning and you also take a B-complex, that is a combination worth mentioning to a pharmacist or a doctor. Not because it is dangerous at these amounts, but because it is the kind of thing that is easy to establish and pointless to guess at.

None of that makes niacin a memory ingredient. It makes it the one row on this label where the missing panel costs a reader the least, because the plausible range is narrow and the consequences at either end of it are well understood. On the five gram-scale rows the same omission hides the difference between a meaningful dose and a token one, and that is a far larger gap to be left guessing about.

So if you are weighing this formula, weigh it as five open questions and one reasonable answer. The ingredients page lays all six out in order with the trial dose beside each, which is the closest a reader can get to the panel that is not there.

References